Join Dr. Yeku for a discussion on novel and emerging immunotherapeutic regimens for the management of gynecologic cancers.

The goal of this activity is to explore and understand the rationale and current and potential role of immunotherapy in the treatment of gynecologic cancers.

This activity is intended for oncologists, obstetricians, gynecologists, and pathologists.

Learning Objectives:

• Have increased knowledge regarding the
  • Clinical trial data around the use of immune checkpoint inhibitor (ICI) regimens in women with gynecological cancers
  • Role of immunotherapeutic biomarkers in women with gynecological cancers
  • Patients with gynecological cancer in whom an immune checkpoint inhibitor regimen should be considered

Approximate Time to Complete: 30 minutes

Credit Available: April 8, 2021 - April 8, 2022

Developed through a partnership between SITC and Medscape.

Additional Resources for Clinicans from SITC: